14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VTGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Tuesday for VistaGen Therapeutics Inc stock after gaining 0.87%
(Updated on May 07, 2024)

Sell candidate since May 02, 2024 Gain 5.67% PDF

The VistaGen Therapeutics Inc stock price gained 0.87% on the last trading day (Tuesday, 7th May 2024), rising from $4.62 to $4.66. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.32% from a day low at $4.52 to a day high of $4.67. The price has risen in 6 of the last 10 days but is still down by -3.52% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 25 thousand more shares were traded than the day before. In total, 135 thousand shares were bought and sold for approximately $629.04 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.86% during the next 3 months and, with a 90% probability hold a price between $3.71 and $5.18 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VTGN Signals & Forecast

There are mixed signals in the stock today. The VistaGen Therapeutics Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.78. On a fall, the stock will find some support from the short-term average at $4.65. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, April 02, 2024, and so far it has fallen -13.70%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). VistaGen Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock

VistaGen Therapeutics Inc finds support from accumulated volume at $4.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.150 between high and low, or 3.32%. For the last week, the stock has had daily average volatility of 5.30%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VTGN) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect VistaGen Therapeutics Inc to open at $4.62, and during the day (based on 14 day Average True Range), to move between $4.40 and $4.92, which gives a possible trading interval of +/-$0.264 (+/-5.66%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 11.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.49 (3.65%) than the resistance at $5.28 (13.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is VistaGen Therapeutics Inc stock A Buy?

VistaGen Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.423 Sell Candidate Unchanged

Predicted Opening Price for VistaGen Therapeutics Inc of Wednesday, May 8, 2024

Fair opening price May 8, 2024 Current price
$4.62 ( 0.93%) $4.66

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VTGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.77 2.29 %
R2 4.71 1.06 %
R1 4.67 0.300 %
Current price: 4.66
Support S1 4.56 -2.16 %
S2 4.52 -2.92 %
S3 4.47 -4.15 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.40 15.88 %
R2 5.29 13.52 %
R1 5.28 13.30 %
Current price 4.66
Support S1 4.49 -3.65%
S2 4.24 -9.12%
S3 4.17 -10.52%

FAQ

What is the symbol for VistaGen Therapeutics Inc Stock and on which exchange is it traded?
The symbol for VistaGen Therapeutics Inc is VTGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.

What's the current price of VistaGen Therapeutics Inc Stock?
As of the end of day on the May 07, 2024, the price of an VistaGen Therapeutics Inc (VTGN) share was $4.66.

What is the 52-week high and low for VistaGen Therapeutics Inc Stock?
The 52-week high for VistaGen Therapeutics Inc Stock is $24.71 and the 52-week low is $1.62.

What is the market capitalization of VistaGen Therapeutics Inc Stock?
As of the May 07, 2024, the market capitalization of VistaGen Therapeutics Inc is 124.856M.

When is the next earnings date for VistaGen Therapeutics Inc?
The upcoming earnings date for VistaGen Therapeutics Inc is Jun 26, 2024.
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT